640
Y L N Murthy et al.
1a-j
3a-j
= Copper ferrite nano particle.
R = (a)C6H5 (b)2-ClC6H4 (c)2-Br,5-F,C6H3 (d)2-Br,5-F,C6H3, (e)Furanyl (f)5-Phenyl,3-Methyl,4-
,
Isoxazolyl, (g)5-(2,5-dichloro)Phenyl,3-Methyl,4Isoxazolyl, (h)(CH3)3C-, (i)C11H23- (j)C15H31-,
Scheme 1. Synthesis of β, γ -unsaturated ketone using allyl bromide.
copper nano ferrite (10 mol%) and stirring was continu- 1058 (C-O-N); 1HNMR (90 MHz, CDCl3/TMS): 8.18–
ed for 30 min at room temperature. Benzoyl chloride 8.22 (m, ArH), 3.67 (d, 2H), 6.29 (m, 1H), 4.96–5.04
(1 mmol) was then added in THF (10 ml) to the reac- (d/d, 2H), 2.49 (s, 3H); 13CNMR (22.5 MHz, CDCl3/
tion mixture and then the reaction was continued for a TMS):174.9, 62.16, 160.53, 132.88, 131.09, 129.15,
certain period of time as required for completion (moni- 128.38, 126.87, 109.92, 42.30, 12.82.
tored by TLC). The reaction mixture was then filtered to
separate the catalyst and the filtrate was quenched with
a few drops of water and the product was extracted with
dichloromethane and the solvent was removed under
reduced pressure. Further purification was attained by
2.2e 1-(3-(2,6-Dichlorophenyl)-5-methylisoxzol-4-yl)
but-3-en-1-one (table 4 entry 7) 3g: IR (υmax, KBr
Pellet in cm− 1): 1712 (-C=O), 1637(-C=C-), 3060
(=C-H), 1645 (C=N), 1069 (C-O-N), 717 (C-Cl);1HNMR
column chromatography, a colourless crystalline com-
(90 MHz, CDCl3/TMS): 7.78–8.34 (m, ArH), 3.97 (d,
pound was formed and recrystalized from ethanol. The
2H), 6.48 (m, 1H), 4.23–4.54 (d/d, 2H), 2.57 (s,3H);
pure compound was then characterized. Spectral data of
13CNMR (22.5 MHz, CDCl3/TMS): 175.74, 162.12,
selected compounds are given below.
158.67, 134.65, 131.97, 128.10, 109.93, 42.29, 12.80.
2.2a 1-Phenyl but-3-en-1-one (table 4 entry 1)3a:12 IR
2.2f 1, 4-Diphnyl-but– 3- en-1 one (table 4 entry 11)
(υmax, KBr Pellet in cm−1): 1701 (-C=O), 1669 (-C=C-),
4a:13 IR (υmax, KBr Pellet in cm−1): 1450, 1598,
1
3009 (=C-H); HNMR (90 MHz, CDCl3/TMS): 7.25–
8.4(ArH, m), 3.89 (2H, d), 5.82–6.09 (1H, m), 5.09–
5.39 (2H, d/d);13C NMR (22.5 MHz, CDCl3/TMS)
δ171.94, 133.77, 130.2,129.4, 128.41,105.07, 42.28.
1679, 3062; 1HNMR (90 MHz, CDCl3/TMS): 3.89 (2H,
br S), 5.82–6.09 (1H, m), 5.09–5.39 (1H, d/d), 7.25–8.4
(ArH,m); 13C NMR (22.5 MHz, CDCl3/TMS): δ171.94,
133.77, 130.2, 129.4, 128.41,105.07, 42.28
2.2b 1-(2-Chloro phenyl) but-3-en-1-one (table 4 entry
2) 3b: IR (υmax, KBr Pellet in cm−1): 1715 (-C=O),
1680 (-C=C-), 3071 (=C-H), 776 (C-Cl);1 HNMR (90 MHz,
CDCl3/TMS): δ7.41–7.93 (m, ArH), 3.33 (d, 2H), 4.76–
5.10 (m, 1H), 4.22 (d/d, 2H); 13CNMR (22.5 MHz, CDCl3/
TMS): δ166.69, 132.55, 131.94, 131.6, 130.73, 127.20,
36.74.
2.2g 1-(2-Chloro phenyl)-4-phenyl-but-3-en-1-one
(table 4 entry 12)4b: IR (υmax, CHCl3 in cm− 1): 725,
1249, 1445, 1593, 1714, 3040; 1HNMR (90 MHz, CDCl3/
TMS): 3.53 (2H, br S), 6.33–6.53 (1H, m), 5.11 (1H,
d/d), 7.32–7.83 (ArH, m);13C NMR (22.5 MHz, CDCl3/
TMS): 165.00, 132.98, 132.87, 132.01, 130.84, 130.51,
130.00, 129.4, 128.00, 127.13, 126.18, 125.54, 44.87.
2.2c 1-(Furan-2-yl) but-3-en-1-one (table 4 entry 5)
3e: IR (υmax, KBr Pellet in cm− 1): 1717 (-C=O), 1648
2.2h 1-Furan-2yl-4-phenyl-but-3en-1-one (table 4 entry
13)4c: IR (υmax, CHCl3 in cm− 1): 1014, 1116, 1473,
1581, 1701, 2877, 3016; 1HNMR (90 MHz, CDCl3/TMS):
3.85 (2H, br S), 6.08 (1H, m), 6.26–6.41 (1H, dd), 6.53–
6.71 (3H, m), 7.31–7.67 (ArH, m); 13C NMR (22.5 MHz,
CDCl3 /TMS): 160.34, 146.09, 144.07, 135.41, 133.51,
1238.08, 126.16, 124.38, 118.91, 111.16, 44.87
1
(-C=C-), 3127 (=C-H), 1077 (C-O-C); HNMR (90 MHz,
CDCl3/TMS): δ7.53, 7.33, 6.78 (m, 3H), 3.6 (d, 2H), 6.57–
6.55 (m, 1H), 4.365.22 (d/d, 2H); 13CNMR (22.5 MHz,
CDCl3/TMS): δ178.28, 162.32, 147.19, 143.92, 119.39,
112.21111.82, 27.67.
2.2d 1-(5-Methyl-3-phenyisoxazol-4-yl) but-3-en-1-one
(table 4 entry 6) 3f :10 IR (υmax, KBr Pellet in cm−1): 1719 2.2i 2-Methyl-6-phenyl-hex-5-en-3-one (table 4 entry
(-C=O), 1599 (-C=C-), 3108 (=C-H), 1678 (C=N), 14)4d: IR (υmax, CHCl3 in cm− 1): 1438, 1593, 1724,